التاريخ:	--/--/-- --:--:--
مُعرِّف الحدث:	E5LE84FFB
نوع الإجراء:	ACQUISITION
حالة الإجراء:	ANNOUNCED
رمز سهم الشركة المستحوِذة:
الرمز المُستهدَف:	PCRX
مُحدَّث:	--/--/-- --:--:--
سعر شراء السهم:	36.5
عملة سعر السهم الواحد:	USD
مصادر الأخبار:	https://www.prnewswire.com/news-releases/viatris-announces-commencement-of-tender-offer-to-acquire-pacira-biosciences-inc-302924916.html

ملاحظات حول الإجراء

Viatris Inc and Pacira BioSciences, Inc today announced that they have entered into a definitive agreement under which Viatris has agreed to acquire all of the outstanding shares of common stock of Pacira for $36.50 per share in cash, representing an aggregate equity value of $1.65 billion. The transaction, which was unanimously approved by the boards of directors of both companies, is subject to customary closing conditions, including the tender of a majority of the outstanding shares of Pacira's common stock and expiration of the applicable regulatory waiting period. Pacira's board of directors unanimously recommends that Pacira's stockholders tender their shares in the tender offer. The transaction is expected to close by the end of 2026.Upon completion of the transaction, Pacira will become a wholly owned subsidiary of Viatris and Pacira's common stock will no longer be listed for trading on the Nasdaq Global Select Market.